Cargando…
Development of an Induced Pluripotent Stem Cell-Based Liver-on-a-Chip Assessed with an Alzheimer’s Disease Drug
[Image: see text] Liver-related drug metabolism is a key aspect of pharmacokinetics and possible toxicity. From this perspective, the availability of advanced in vitro models for drug testing is still an open need, also to the end of reducing the burden of in vivo experiments. In this scenario, orga...
Autores principales: | Fanizza, Francesca, Boeri, Lucia, Donnaloja, Francesca, Perottoni, Simone, Forloni, Gianluigi, Giordano, Carmen, Albani, Diego |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10336847/ https://www.ncbi.nlm.nih.gov/pubmed/37318190 http://dx.doi.org/10.1021/acsbiomaterials.3c00346 |
Ejemplares similares
-
Induced pluripotent stem cell-based organ-on-a-chip as personalized
drug screening tools: A focus on neurodegenerative disorders
por: Fanizza, Francesca, et al.
Publicado: (2022) -
Human gut epithelium features recapitulated in MINERVA 2.0 millifluidic organ-on-a-chip device
por: Donnaloja, Francesca, et al.
Publicado: (2023) -
Unravelling the mechanotransduction pathways in Alzheimer’s disease
por: Donnaloja, Francesca, et al.
Publicado: (2023) -
Technological tools and strategies for culturing human gut microbiota in engineered in vitro models
por: Sardelli, Lorenzo, et al.
Publicado: (2021) -
Advanced Organ-on-a-Chip Devices to Investigate Liver Multi-Organ Communication: Focus on Gut, Microbiota and Brain
por: Boeri, Lucia, et al.
Publicado: (2019)